Physician profile
William J Hale
NPI 1215917778
$5,641.46
in general payments reported to CMS, 2019-2025
13 companies · $545 in 2025
The $545 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $712 · 2020: $12.27 · 2021: $1,355 · 2022: $1,638 · 2023: $1,144 · 2024: $235 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,010 · Food and Beverage: $914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,009.91 |
| Food and Beverage | $913.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $3,214.23 | 2019-2024 | |
| Arthrex, INC. | $1,289.91 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $440.11 | 2019-2025 | Mymobility Platform, Gel-One Cross-Linked Hyaluronate, Persona |
| Stryker Corporation | $197.10 | 2021-2022 | |
| Orthalign INC | $196.96 | 2022-2025 | Orthalign Plus |
| P Bar Medical LLC | $88.02 | 2025 | |
| Maruho Medical, INC. | $56.13 | 2021 | |
| Carbofix Orthopedics INC | $46.90 | 2021 | |
| Depuy Synthes Sales INC. | $35.11 | 2019-2024 | Tfn-Advance |
| Spr Therapeutics, INC | $30.54 | 2025 | Sprint Pns System |
| Smith+Nephew, INC. | $21.67 | 2019 | |
| Horizon Therapeutics Plc | $12.51 | 2019 | |
| Pfizer INC. | $12.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.